Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Veronica H. Flood MD
Associate Professor
Department of Pediatrics
Division of Hematology/Oncology

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

CITIZENSHIP:  USA

EDUCATION:
8/1991 - 6/1995 AB in Biology Anthropology, Harvard College, Cambridge, MA
8/1995 - 5/1999 MD, Tufts University School of Medicine, Boston, MA

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
6/1999 - 6/2002 Resident, Pediatrics, Phoenix Children's Hospital/Maricopa Medical Center, Phoenix, AZ
7/2002 - 6/2005 Fellow, Pediatrics, Hematology/Oncology, Oregon Health & Science University, Portland, OR

FACULTY APPOINTMENTS:
7/2005 - 7/2006 Instructor, Pediatrics, Oregon Health & Science University, Portland, OR
8/2006 - Present Assistant Professor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
1/2009 - Present Fellowship Hematology Rotation Coordinator, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
7/2005 - 7/2006 Medical Staff, Oregon Health & Science University (OHSU), 3181 S.W. Sam Jackson Park Rd., Portland, OR 97239
7/2005 - 7/2006 Medical Staff, OHSU Doernbecher Children's Hospital, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97239
8/2006 - Present Medical Staff, Hematology/Oncology/BMT, Children's Hospital of Wisconsin, 9000 W. Wisconsin Ave., Milwaukee, WI 53226
8/2006 - Present Medical Staff, Hematology, Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Pediatrics
10/2002
2012
American Board of Pediatrics - Hematology/Oncology
11/2006
2013
 
Certificates
Issued By Issue DateExpiration
BLS
AHA
4/2010
4/2012
PALS
AHA
4/2010
4/2012
 
Licensure
Number Issue DateExpiration
Wisconsin Medical License
7/26/2006
10/31/2013
 
AWARDS AND HONORS:
9/2003 - 6/2005 Human Investigations Program, OHSU
7/2004 - 6/2005 Chief Pediatric Fellow - elected chief of all pediatric fellows, OHSU
9/2004 - 8/2010 Pediatric Research Loan Repayment Program, National Institutes of Health
6/2005 "Outstanding Research by a Pediatric Fellow" Award, OHSU Doernbecher Children's Hospital
8/2007 - 5/2008 Clinical Research Training - selected to be one of 20 participants nationally for this mentored research program, American Society of Hematology Clinical Training Institute, Dana Point, CA
9/2011 - 9/2013 Clinical Research Scholars Program, Medical College of Wisconsin Clinical Translational and Science Institute

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
7/2002 - Present American Society of Hematology
7/2002 - Present American Society of Hematology/Oncology
10/2005 - Present American Academy of Pediatrics
1/2006 - Present Hemophilia and Thrombosis Research Society
1/2007 - Present International Society on Thrombosis and Haemostasis

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
12/2006 - Present Pediatric Blood and Cancer
12/2007 - Present Blood
1/2008 - Present Pediatrics
10/2009 - Present Journal of Pediatric Hematology/Oncology
2/2010 - Present Haemophilia
11/2010 - Present Thrombosis
11/2010 - Present Journal of Thrombosis and Haemostasis
4/2011 - Present International Journal of Laboratory Hematology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
3/2004 - 12/2004 Contract Physician, Oregon State Newborn Screen Lab, Oregon Health and Science University
7/2004 - 6/2005 Pediatric Fellowship Committee, Oregon Health and Science University
3/2006 - 7/2006 Founding Director, Pediatric Thrombosis Clinic, OHSU Doernbecher Children's Hospital

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Functional Implications of VWF A1 Domain Polymorphisms
Source:
National Institutes of Health (NHLBI) K08 award
Role:
Principal Investigator
Dates:
7/1/2010 - 4/30/2015
Direct Funds:
$500,000
 
Non-Peer Review
Title:
Studies of VWF Function
Source:
MACC Fund Center for Cancer and Blood Disorders
Role:
Principal Investigator
Dates:
7/1/2010 - 6/30/2011
Direct Funds:
$50,000
 
Prior
Peer Review
Title:
Molecular Characterization of a Human Dysfibrinogen
Source:
NIH NRSA F32 award
Role:
Principal Investigator
Dates:
8/1/2004 - 7/21/2006
 
Title:
Molecular Characterization of Human Dysfibrinogens
Source:
Tartar Trust Foundation
Role:
Principal Investigator
Dates:
7/1/2005 - 6/30/2006
Direct Funds:
$2,000
 
Title:
Implications of Von Willebrand Factor-Factor VIII Interactions
Source:
Children's Research Institute
Role:
Principal Investigator
Dates:
2/1/2007 - 7/31/2008
Direct Funds:
$25,000
 
Title:
Implications of von Willebrand Factor-Factor VIII Interactions
Source:
Hemophilia and Thrombosis Research Society
Role:
Principal Investigator
Dates:
7/1/2008 - 6/30/2010
Direct Funds:
$138,888
 
Title:
Studies of VWF Function in VWF-Platelet and VWF-FVIII Interactions
Source:
National Hemophilia Foundation
Role:
Principal Investigator
Dates:
7/1/2008 - 6/30/2010
Direct Funds:
$129,630
 
Non-Peer Review
Title:
Molecular Characterization of Human Dysfibrinogens
Source:
Oregon Health & Sciences General Clinical Research Center
Role:
Principal Investigator
Dates:
7/1/2004 - 7/21/2006
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1. Von Willebrand Disease, Wheaton Franciscan Health Care-All Saints Grand Rounds, Racine, WI, 11/2008
2. The VWF A1 Domain: Minor Changes in Sequence, Major Changes in Function, Puget Sound Blood Center, Seattle, WA, 6/2011
 
Regional
1. Von Willebrand Disease: Update on Diagnosis and Treatment, Great Lakes Hemophilia Foundation (GLHF) Fun and Education Weekend, Green Bay, WI, 6/2007
2. Clots and Catheters, WAPHON (Wisconsin Advanced Practice Hematology Oncology Nurses) Educational Meeting, Milwaukee, WI, 9/2009
 
National
1. VWF-FVIII Interactions, Hemophilia and Thrombosis Research Society Industry Summit, Chicago, IL, 9/2008
2. Limitations of the VWF Ristocetin Cofactor Activity Assay, National Hemophilia Foundation 61st Annual Meeting, San Francisco, CA, 10/2009
3. A1 Domain Polymorphisms In Assays of VWF Function, CSL Behring VWD Leadership Advisory Board Meeting, Wilmington, DE, 10/2010
 
International
1. VWF Polymorphisms Can Sabotage the VWF:RCo Assay of VWF Function, 6th Bari International Conference, Pugnochiuso, Italy, 5/2008
 
PEER REVIEWED WORKSHOPS/PRESENTATIONS:
Local
1. Flood VH, Anemia and Jaundice in a Two Year Old Boy, Mayo Clinic Scottsdale Academic Excellence Day - Poster Presentation, Scottsdale, AZ, 5/2001
2. Flood VH, The Case of the Swollen Knee, Mayo Clinic Scottsdale Academic Excellence Day - Poster Presentation, Scottsdale, AZ, 5/2002
3. Sheppard A, Flood VH, Characterization of Variant Fibrinogens, Northwest Undergraduate Science Research Conference - Oral Presentation, Portland, OR, 4/2005
4. Flood VH, The Fibrinogen A(alpha)R16C Mutation Results in Fibrinolytic Resistance, OHSU Heart Research Center Retreat, Portland, OR, 10/2005
5. Johnson C, Flood VH, Characterization of Acquired Dysfibrinogenemia in Liver Cirrhosis, Northwest Undergraduate Science Research Conference - Oral Presentation, Portland, OR, 4/2006
 
National
1. Flood VH, Johnson FL, Boshkov LK, Nugent DJ, Thomas GA, Nicholson HS, Tilford D, Godder KT, Sustained Engraftment Post Bone Marrow Transplant Despite Anti-Platelet Antibodies in Glanzmann Thrombasthenia, American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting - Poster Presentation, San Francisco, CA, 5/2004
2. Flood VH, Al-Mondhiry HA, Farrell DH, The Paradoxical Hemorrhagic and Thrombotic Nature of the Fibrinogen A alpha R16C Mutation, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, San Diego, CA, 12/2004
3. Flood VH, Al-Mondhiry HA, Bakke AC, Farrell DH, Fibrinogen Hershey IV: A Novel Dysfibrinogen with a  V411I Mutation in the Integrin IIb3 Binding Site, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, Atlanta, GA, 12/2005
4. Flood VH, Galderisi FC, Lowas SR, Boshkov LK, Late Hemorrhagic Disease of the Newborn in Two Patients Receiving Vitamin K at Birth: Recognition and Treatment with Recombinant Factor VIIa, Vitamin K, and Plasma, Hemophilia & Thrombosis Research Society Meeting - Poster Presentation, Chicago, IL, 4/2006
5. Flood VH, Nagaswami C, Chernysh IN, Al-Mondhiry HA, Weisel JW, Farrell DH, Effects of Impaired Fibrinopeptide A Cleavage on Fibrin Clot Structure: Studies with an A R16C Dysfibrinogen, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, Orlando, FL, 12/2006
6. Bellissimo DB, Christopherson PA, Haberichter SL, Flood VH, Gill JC, Friedman KD, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR, Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD), American Society of Hematology (ASH) Annual Meeting - Oral Presentation, Atlanta, GA, 12/2007
7. Montgomery RR, Morateck P, Christopherson PA, Kautza BC, Miller CA, Branchford BR, Flood VH, Haberichter SL, Bellissimo DB, Friedman KD, Kenny DJ, Gill JC, Functional Assay of VWF Measured by its Interaction with Platelet GPIb without the Use of Ristocetin, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, Atlanta, GA, 12/2007
8. Flood VH, Kautza BC, Miller CA, Branchford BR, Gill JC, Haberichter SL, Morateck PA, Christopherson PA, Perry CL, Friedman KD, Bellissimo DB, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Lillicrap D, Goodeve AC, Peake IR, Montgomery RR, Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, Atlanta, GA, 12/2007
9. Flood VH, Kautza BC, Miller CA, Branchford BR, Gill JC, Haberichter SL, Morateck PA, Christopherson PA, Perry CL, Friedman KD, Bellissimo DB, Abshire TC, Lusher JM, Hoots WK, Shapiro AD, Di Paola JA, Leissinger C, Ragni MV, Lillicrap D, Goodeve AC, Peake IR, Montgomery RR, The Impact of Common VWF Polymorphisms in African Americans and Caucasians on Laboratory Tests of VWF Function, Gordon Research Conference on Hemostasis - Poster Presentation, Waterville Valley, NH, 7/2008
10. Gill JC, Christopherson PA, Flood VH, Friedman KD, Montgomery RR, Zimmerman Program Investigators, Bleeding Scores in von Willebrand Disease (VWD) Re-visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, San Francisco, CA, 12/2008
11. Flood VH, Morateck PA, Christopherson PA, Friedman KD, Gill JC, Montgomery RR, Zimmerman Program Investigators, Unique ELISA-Based Assays for VWF-GPIb Interactions and the Impact of Racial Differences on VWF Testing, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, San Francisco, CA, 12/2008
12. Flood VH, Lederman CA, Wren JS, Christopherson PA, Friedman KD, Montgomery RR, A Novel VWF A3 Domain Mutation with Absent Binding to Type I and Type III Collagen, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, New Orleans, LA, 12/2009
13. Flood VH, Lederman CA, Wren JS, Christopherson PA, Friedman KD, Montgomery RR, Absent Collagen Binding in a VWF A3 Domain Mutant: Utility of the VWF:CB in Diagnosis of VWD, Gordon Research Conference on Hemostasis - Poster Presentation, Waterville Valley, NH, 7/2010
14. Flood VH, Haberichter SL, Friedman KD, Lentz SR, Gill JC, Montgomery RR , VWF Binding to Types I, III, or VI Collagen in the ZPMCB-VWD with Identification of Subjects with Selective Reduced Plasma VWF:CB, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, Orlando, FL, 12/2010
15. Flood VH, Wren JS, Haberichter SL, Friedman KD, Bellissimo DB, Gill JC, Hoffmann RG, Scott JP, Montgomery RR, Low VWF:RCo in Subjects with VWF Polymorphisms P1472H and P1467S Due to Decreased Binding of Ristocetin to the VWF A1 Domain, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, Orlando, FL, 12/2010
16. Friedman KD, Bellissimo, D.B., Christopherson PA, Flood VH, Gill JC, Montgomery RR, Haberichter SL, Fourteen Percent of Healthy African Americans Participating in the Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD) are Heterozygous for the VWF Gene Mutation H817Q Associa, American Society of Hematology (ASH) Annual Meeting - Oral Presentation, Orlando, FL, 12/2010
17. Haberichter SL, Jacobi PM, Flood VH, Christopherson PA, Gill JC, Bellissimo DB, Friedman KD, Zimmerman Program Investigators, Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, San Diego, CA, 12/2011
18. Montgomery RR, Christopherson PA, Haberichter SL, Flood VH, Gill JC, Zimmerman Program Investigators, Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, San Diego, CA, 12/2011
19. Flood VH, Gill JC, Friedman KD, Christopherson PA, Jacobi PM, Montgomery RR, Haberichter SL, Von Willebrand Factor Collagen Binding Provides a Sensitive Screen for Identification of Type 2A and 2B Von Willebrand Disease, American Society of Hematology (ASH) Annual Meeting - Poster Presentation, San Diego, CA, 12/2011
 
International
1. Flood VH, Al-Mondhiry HA, Farrell DH, The Fibrinogen A R16C Mutation Results in Fibrinolytic Resistance, International Society on Thrombosis and Haemostasis (ISTH) XX Congress- Oral Presentation, Sydney, Australia, 8/2005
2. Branchford BR, Kautza BC, Gill JC, Flood VH, Friedman KD, Lee A, Morateck P, Christopherson PA, Montgomery RR, Racial Disparity in the Diagnosis of von Willebrand Disease (VWD) with Particular Reference to the Diagnosis of Type 2M VWD in African Americans, Pediatric Academic Society - Poster Presentation, Toronto, Canada, 5/2007
3. Flood VH, Morateck PA, Christopherson PA, Gill JC, Friedman KD, Montgomery RR, Zimmerman Program Investigators, Functional Assays for Discrimination of Type 2 VWD Variants, International Society on Thrombosis and Haemostasis (ISTH) XXII Congress - Oral Presentation, Boston, MA, 7/2009
4. Flood VH, Haberichter SL, Friedman KD, Lentz SR, Hoffmann RG, Gill JC, Montgomery RR, Utility of von Willebrand Factor Collagen Binding Assays (VWF:CB) with Type VI Collagen in the Diagnosis of VWD, International Society on Thrombosis and Haemostasis - Poster Presentation, Kyoto, Japan, 7/2011
5. Flood VH, Haberichter SL, Friedman KD, Lentz SR, Hoffmann RG, Gill JC, Montgomery RR, Utility of von Willebrand Factor Collagen Binding Assays (VWF:CB) with Type VI Collagen in the Diagnosis of VWD, International Society on Thrombosis and Haemostasis (ISTH) XXIII Congress - Poster Presentation, Kyoto, Japan, 7/2011
 
COMMITTEE SERVICE:
Medical College
1/2008 - Present Member, Fellowship Selection Committee, Hematology/Oncology/BMT, Pediatrics, Medical College of Wisconsin
9/2009 Poster Reviewer, Medical Student Research Day, Medical College of Wisconsin
10/2009 - Present Member, Search Committee for Comprehensive Center for Bleeding Disorders (CCBD) Director, Hematology, Pediatrics, Medical College of Wisconsin
2/2010 - Present Member, Website Redesign Committee, Hematology, Pediatrics, Medical College of Wisconsin
7/2011 - Present Member, Women's Faculty Council, Medical College of Wisconsin
8/2011 - Present Member, Faculty Career Development Committee, Medical College of Wisconsin
2011 - Present Co-Chair, Clinical Integration Committee, Pediatrics, Medical College of Wisconsin
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
1/2007 - Present Oversee 3rd and 4th year medical students covering hematology patients on the inpatient hematology service (initially four weeks per year, increased to six weeks per year in 2009)
8/2010 - Present Review H&Ps for 3rd year medical students on their pediatric rotation (approximately 4 hours per month, 4 months per year)
3/2011 - Present Assisting in developing module for coagulation teaching as part of coagulation curriculum for second year medical students as part of the new curriculum
1/2012 - Present Teaching coagulation module as part of coagulation curriculum for second year medical students
 
Resident and Fellow Education
1/2007 - Present Oversee 1st year residents covering hematology patients on the inpatient hematology service (initially four weeks per year, increased to six weeks per year in 2009)
1/2007 - Present Supervise fellows in hematology clinic, on inpatient service, and during weekend call, including: General hematology clinic, Coagulation clinic, Hematology inpatient service six weeks per year
1/2007 - Present Oversee residents in hematology clinic during their outpatient hematology rotation elective (12 hours per month)
9/2007 - Present Fellowship curriculum lectures: Congenital and Acquired Anemia; Nutritional Anemias; Qualitative Disorders of Neutrophils; Quantitative Disorders of Neutrophils
9/2010 Ace the Boards Pediatric Board Review Course, Hematology for the Pediatric Board Review, Lecture for review course intended for pediatric residents
1/2011 Core curriculum lecture for residents on coagulation disorders, Inherited and Acquired Bleeding Disorders: Coagulation Factors
2/2011 Core curriculum lecture for residents on platelet disorders, Inherited and Acquired Bleeding Disorders: Platelets
9/2011 Ace the Boards Pediatric Board Review Course, Hematology for the Pediatric Board Review, Lecture for review course intended for pediatric residents
 
Continuing Medical Education
3/2008 Children's Research Institute Academic Conference Presentation - Common VWF Polymorphisms and Their Effect on Assays of VWF Function
9/2008 Team Conference, Child Advocacy Center Presentation - Common Bleeding Disorders and Child Abuse
2/2010 Hematology/Oncology Nursing Conference Presentation - Pediatric Bleeding Disorders
2/2011 Children's Research Institute Academic Conference Presentation - Clinical Implications of VWF A1 Domain Polymorphisms
5/2011 Pediatric Hematology/Oncology Conference Presentation - The Importance of VWF-Collagen Interactions
 
EXTRAMURAL TEACHING (e.g. at Marquette, UWM, etc.):
Community/Lay Public
1/2006 Oregon Health & Science University, Oregon Hematology Update Conference, ASH Update: Hemostasis
 
Medical Student Education
4/2005 - 4/2006 Oregon Health & Science University, Biological Basis of Disease, small group leader, Coagulation Disorders, Transfusion Medicine, Red Cell Disorders, Inherited Thrombotic Disorders
3/2006 Oregon Health & Science University, Biological Basis of Disease, lecturer, Inherited Bleeding Disorders
 
Resident and Fellow Education
1/2003 Oregon Health & Science University, Doernbecher Children's Hospital Grand Rounds, Lymphomatoid Granulomatosis
1/2006 Oregon Health & Science University, Doernbecher Children's Hospital Grand Rounds, Update on Management of Pediatric Deep Venous Thrombosis
 
Continuing Medical Education
11/2003 Oregon Health & Science University, Doernbecher Children's Hospital Nursing Education Day Presentation - Immune Thrombocytopenic Purpura Portland, OR
11/2004 Oregon Health & Science University, Doernbecher Children's Hospital Nursing Education Day Presentation - Pediatric Anemia
3/2006 Oregon Health & Science University, Physician Assistant Student Education Presentation - Inherited Bleeding Disorders
7/2008 Children’s Specialty Group, Best Practices in Pediatrics Presentation - Common Bleeding Disorders in Pediatric Practice
 
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
Dana Larsen, Medical College of Wisconsin, 5/2011 - 8/2011 laboratory mentor for summer project on VWD
 
Medical Students
Benjamin Kautza, Medical College of Wisconsin, 5/2007 - 11/2008 Laboratory mentor during his rotations with Dr. Montgomery
Amanda Martin, Medical College of Wisconsin, 1/2011 - Present Pathway Advisor starting in first year of medical school
 
Clinical/Research Fellows
Dr. Hema Rangarajan , Medical College of Wisconsin, 11/2009 - Present Scholarship Oversight Committee
Dr. Samip Kothari , Medical College of Wisconsin, 2/2010 Mentor for Physiology Conference talk on neonatal hemostasis
 
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
Amara Sheppard, Oregon Health & Science University, 5/2004 - 4/2005 Project Mentor
Cassie Johnson, Oregon Health & Science University, 5/2005 - 4/2006 Project Mentor
 
PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Fellow
Pediatric Hematology/Oncology Fellowship Hematology Rotation Coordinator - coordinate all clinical aspects of hematology rotation, assist with journal club, research and clinical mentoring, teaching
 
 
 
 
COMMUNITY SERVICE ACTIVITIES:
8/2003 - 8/2004 Camp physician, Camp Tapawingo, Falls City, OR
1/2008 - Present Alumni Interviewer for Harvard College


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Flood VH, Johnson FL, Boshkov LK, Thomas GA, Nugent DJ, Bakke AC, Nicholson HS, Tilford D, Brown MP, Godder KT Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia. Pediatr Blood Cancer. 2005 Dec;45(7):971-5
2. Flood VH, Al-Mondhiry HA, Farrell DH The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance. Br J Haematol. 2006 Jul;134(2):220-6
3. Flood VH, Nagaswami C, Chernysh IN, Al-Mondhiry HA, Weisel JW, Farrell DH Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability. Br J Haematol. 2007 Jul;138(1):117-24
4. Flood VH, Galderisi FC, Lowas SR, Kendrick A, Boshkov LK Hemorrhagic disease of the newborn despite vitamin K prophylaxis at birth. Pediatr Blood Cancer. 2008 May;50(5):1075-7
5. Flood VH, Al-Mondhiry HA, Rein CM, Alexander KS, Lovely RS, Shackleton KM, David LL, Farrell DH Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site. Thromb Haemost. 2008 Jun;99(6):1008-12
6. Flood VH, Friedman KD, Gill JC, Morateck PA, Wren JS, Scott JP, Montgomery RR Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. J Thromb Haemost. 2009 Nov;7(11):1832-9
7. Flood VH, Lederman CA, Wren JS, Christopherson PA, Friedman KD, Hoffmann RG, Montgomery RR Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD. J Thromb Haemost. 2010 Jun;8(6):1431-3
8. Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Branchford BR, Hoffmann RG, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. Blood. 2010 Jul 15;116(2):280-6
9. Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Hoffmann RG, Montgomery RR Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. Blood. 2011 Feb 10;117(6):e67-74
10. Flood VH, Gill JC, Friedman KD, Bellissimo DB, Haberichter SL, Montgomery RR Von Willebrand disease in the United States: a perspective from Wisconsin. Semin Thromb Hemost. 2011 Jul;37(5):528-34
11. Bellissimo DB, Christopherson PA, Flood VH, Gill JC, Friedman KD, Haberichter SL, Shapiro AD, Abshire TC, Leissinger C, Hoots WK, Lusher JM, Ragni MV, Montgomery RR Von Willebrand factor mutations and new sequence variations identified in healthy controls are more frequent in the African-American population. Blood. 2011 Dec 23:
12. Jacobi PM, Gill JC, Flood VH, Jakab DA, Friedman KD, Haberichter SL Intersection of mechanisms of type 2A von Willebrand disease through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage. Blood. 2012 Mar 19:
13. Flood VH, Cox Gill J, Christopherson PA, Bellissimo DB, Friedman KD, Haberichter SL, Lentz SR, Montgomery RR Critical VWF A1 Domain Residues Influence Type VI Collagen Binding. J Thromb Haemost. 2012 Apr 16:
14. Flood VH, Cox Gill J, Christopherson PA, Wren JS, Friedman KD, Haberichter SL, Hoffmann RG, Montgomery RR Comparison of Type I, Type III, and Type VI Collagen Binding Assays in Diagnosis of VWD. J Thromb Haemost. 2012 Apr 16:
15. Franzblau EB, Punzalan RC, Friedman KD, Roy A, Bilen O, Flood VH Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement. Pediatr Blood Cancer. 2012 Nov 5:
16. Flood VH, Gill JC, Friedman KD, Christopherson PA, Jacobi PM, Hoffmann RG, Montgomery RR, Haberichter SL, the Zimmerman Program Investigators Collagen Binding Provides a Sensitive Screen for Variant von Willebrand Disease. Clin Chem. 2013 Jan 22:
17. Larsen DM, Haberichter SL, Gill JC, Shapiro AD, Flood VH Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease. Haemophilia. 2013 Mar 18:
18. Flood VH, Friedman KD, Gill JC, Haberichter SL, Christopherson PA, Branchford BR, Hoffmann RG, Abshire TC, Dunn AL, Di Paola JA, Hoots WK, Brown DL, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation. Blood. 2013 May 2;121(18):3742-4
19. Dobrozsi S, Flood VH, Panepinto J, Scott JP, Brandow A Vitamin B12 deficiency: The great masquerader. Pediatr Blood Cancer. 2013 Sep 21:
20. Flood VH Perils, Problems, and Progress in Laboratory Diagnosis of von Willebrand Disease. Semin Thromb Hemost. 2013 Dec 12:
 
Books, Chapters, and Reviews
1. Flood VH. In: Blueprints Q&A Step 2: Pediatrics. Blackwell Science. Malden, MA; 2002, contributor.
2. Flood VH. In: Blueprints Q&A Step 3: Pediatrics. Blackwell Science. Malden, MA; 2002, contributor.
3. Flood VH, Montgomery RR. In: Von Willebrand Disease: Biological Diagnosis. Lee C, Berntorp E, Hoots K (eds). Textbook of Hemophilia, 2nd edition. Oxford, UK: Wiley-Blackwell;2010.
4. Flood VH, Recht M. Autoimmune Hemolytic Anemia. In: Elzouki AY, (ed). Textbook of Clinical Pediatrics, 2nd edition. Springer;2012 in press.
5. Punzalan RC, Flood VH. Developmental Hemostasis. In: Elzouki AY, ed. Textbook of Clinical Pediatrics, 2nd edition. Springer;2012 in press.
 
Abstracts
1. Flood VH, Johnson FL, Boshkov LK, Nugent DJ, Thomas GA, Nicholson HS, Tilford D, Godder KT. Sustained Engraftment Post Bone Marrow Transplant Despite Anti-Platelet Antibodies in Glanzmann Thrombasthenia. Pediatr Blood Cancer. 2004;42(6):507
2. Flood VH, Al-Mondhiry HA, Farrell DH. The Paradoxical Hemorrhagic and Thrombotic Nature of the Fibrinogen A R16C Mutation. Blood (ASH Annual Meeting Abstracts). 2004;104(11):1047
3. Flood VH, Al-Mondhiry HA, Farrell DH. The Fibrinogen A R16C Mutation Results in Fibrinolytic Resistance. J Thromb Haemost. 2005;3(Suppl 1):109
4. Flood VH, Al-Mondhiry HA, Bakke AC, Farrell DH. Fibrinogen Hershey IV: A Novel Dysfibrinogen with a  V411I Mutation in the Integrin IIb3 Binding Site. Blood (ASH Annual Meeting Abstracts). 2005;106(11):2133
5. Flood VH, Nagaswami C, Chernysh IN, Al-Mondhiry HA, Weisel JW, Farrell DH. Effects of Impaired Fibrinopeptide A Cleavage on Fibrin Clot Structure: Studies with an A R16C Dysfibrinogen. Blood (ASH Annual Meeting Abstracts). 2006;108(11):1617
6. Montgomery RR, Morateck P, Christopherson PA, Kautza BC, Miller CA, Branchford BR, Flood VH, Haberichter SL, Bellissimo DB, Friedman KD, Kenny DJ, Gill JC. Functional Assay of VWF Measured by its Interaction with Platelet GPIb without the Use of Ristocetin. Blood (ASH Annual Meeting Abstracts). 2007;110(11):5212
7. Bellissimo DB, Christopherson PA, Haberichter SL, Flood VH, Gill JC, Friedman KD, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR. Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD). Blood (ASH Annual Meeting Abstracts). 2007;110(11):709
8. Flood VH, Kautza BC, Miller CA, Branchford BR, Gill JC, Haberichter SL, Morateck PA, Christopherson PA, Perry CL, Friedman KD, Bellissimo DB, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Lillicrap D, Goodeve AC, Peake IR, Montgomery RR. Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing. Blood (ASH Annual Meeting Abstracts). 2007;110(11):714
9. Flood VH, Morateck PA, Christopherson PA, Friedman KD, Gill JC, Montgomery RR, and the Zimmerman Program Investigators. Unique ELISA-Based Assays for VWF-GPIb Interactions and the Impact of Racial Differences on VWF Testing. Blood (ASH Annual Meeting Abstracts). 2008;112(11):423
10. Gill JC, Christopherson PA, Flood VH, Friedman KD, Montgomery RR, and the Zimmerman Program Investigators. Bleeding Scores in von Willebrand Disease (VWD) Re-visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD. Blood (ASH Annual Meeting Abstracts). 2008; 112(11):425
11. Flood VH, Morateck PA, Christopherson PA, Gill JC, Friedman KD, Montgomery RR, Zimmerman Program Investigators. Functional Assays for Discrimination of Type 2 VWD Variants. J Thromb Haemost. 2009;7(Suppl 2):2479
12. Flood VH, Lederman CA, Wren JS, Christopherson PA, Friedman KD, Montgomery RR. A Novel VWF A3 Domain Mutation with Absent Binding to Type I and Type III Collagen. Blood (ASH Annual Meeting Abstracts). 2009;114(22):541
13. Friedman KD, Bellissimo DB, Christopherson PA, Flood VH, Gill JC, Montgomery RR, Haberichter SL. Fourteen Percent of Healthy African Americans Participating in the Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD) are Heterozygous for the VWF Gene Mutation H817Q Associated with Type 2N von Willebrand Disease. Blood (ASH Annual Meeting Abstracts). 2010;116(21):239
14. Flood VH, Wren JS, Haberichter SL, Friedman KD, Bellissimo DB, Gill JC, Hoffmann RG, Scott JP, Montgomery RR. Low VWF:RCo in Subjects with VWF Polymorphisms P1472H and P1467S Due to Decreased Binding of Ristocetin to the VWF A1 Domain. Blood (ASH Annual Meeting Abstracts). 2010;116(21):2208
15. Flood VH, Haberichter SL, Friedman KD, Lentz SR, Gill JC, Montgomery RR. VWF Binding to Types I, III, or VI Collagen in the ZPMCB-VWD with Identification of Subjects with Selective Reduced Plasma VWF:CB. Blood (ASH Annual Meeting Abstracts). 2010;116(21):235
16. Flood VH, Haberichter SL, Friedman KD, Lentz SR, Hoffmann RG, Gill JC, Montgomery RR. Utility of von Willebrand Factor Collagen Binding Assays (VWF:CB) with Type VI Collagen in the Diagnosis of VWD. J Thromb Haemost. 2011 Jul;9 (Suppl s2)
17. Haberichter SL, Jacobi PM, Flood VH, Christopherson PA, Gill JC, Bellissimo DB, Friedman KD, Zimmerman Program Investigators. Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes. Blood (ASH Annual Meeting Abstracts). 2011;118:1215
18. Flood VH, Gill JC, Friedman KD, Christopherson PA, Jacobi PM, Montgomery RR, Haberichter SL. Von Willebrand Factor Collagen Binding Provides a Sensitive Screen for Identification of Type 2A and 2B Von Willebrand Disease. Blood (ASH Annual Meeting Abstracts). 2011;18:379
19. Montgomery RR, Christopherson PA, Haberichter SL, Flood VH, Gill JC, Zimmerman Program Investigators. Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD. Blood (ASH Annual Meeting Abstracts). 2011;118:381